series-a
Stage
1
Investors
About
Myrodia Therapeutics develops novel medicines based on 'sensory drug discovery,' a technology that artificially induces protective biological states such as artificial hibernation to treat acute and difficult diseases.
Explore Myrodia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.